VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,000 | -33.3% | 270 | 0.0% | 0.00% | – |
Q4 2017 | $6,000 | +50.0% | 270 | 0.0% | 0.00% | – |
Q3 2017 | $4,000 | -100.0% | 270 | -100.0% | 0.00% | -100.0% |
Q2 2017 | $9,545,000 | +57.3% | 550,944 | 0.0% | 0.04% | +95.5% |
Q1 2017 | $6,068,000 | -77.8% | 550,944 | -59.7% | 0.02% | -52.2% |
Q4 2016 | $27,345,000 | +39.4% | 1,366,945 | +70.7% | 0.05% | -37.8% |
Q3 2016 | $19,611,000 | +21.6% | 800,789 | 0.0% | 0.07% | +17.5% |
Q2 2016 | $16,123,000 | -57.3% | 800,789 | -3.4% | 0.06% | -31.5% |
Q1 2016 | $37,716,000 | -78.5% | 829,236 | -51.5% | 0.09% | -87.8% |
Q4 2015 | $175,085,000 | -47.5% | 1,708,672 | -8.5% | 0.76% | -45.8% |
Q3 2015 | $333,666,000 | -30.4% | 1,867,832 | -13.6% | 1.40% | -14.2% |
Q2 2015 | $479,672,000 | +12.1% | 2,162,329 | +0.0% | 1.63% | +1.1% |
Q1 2015 | $427,850,000 | -10.2% | 2,162,013 | -35.0% | 1.61% | +9.0% |
Q4 2014 | $476,554,000 | -2.8% | 3,328,612 | -11.0% | 1.48% | -7.7% |
Q3 2014 | $490,057,000 | +22.8% | 3,738,456 | +18.4% | 1.60% | +27.2% |
Q2 2014 | $399,075,000 | +68.7% | 3,156,925 | +70.6% | 1.26% | +54.6% |
Q1 2014 | $236,566,000 | +27.0% | 1,850,036 | +16.6% | 0.81% | +13.5% |
Q4 2013 | $186,210,000 | +41.9% | 1,586,303 | +26.0% | 0.72% | +23.0% |
Q3 2013 | $131,234,000 | -11.5% | 1,259,233 | -26.8% | 0.58% | -10.5% |
Q2 2013 | $148,329,000 | – | 1,720,943 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |